GlassScriptPhysician profile
Timothy A Morgan
NPI 1578540159
$1,082.40
in general payments reported to CMS, 2019-2025
18 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $235 · 2024: $257 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,082.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $241.02 | 2025 | Xyosted |
| Edwards Lifesciences Corporation | $159.81 | 2023 | |
| Abbvie INC. | $147.33 | 2024-2025 | |
| Novo Nordisk INC | $91.18 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Gilead Sciences, INC. | $62.96 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $53.56 | 2023-2025 | Airsupra, Farxiga |
| Phathom Pharmaceuticals, INC. | $52.04 | 2025 | Voquezna |
| Lilly USA, LLC | $49.52 | 2024-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $43.40 | 2023-2025 | |
| Viiv Healthcare Company | $33.80 | 2024 | Apretude |
| Ucb, INC. | $25.42 | 2024 | Briviact |
| Amgen INC. | $23.52 | 2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $18.98 | 2024 | |
| Dexcom, INC. | $18.64 | 2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $17.90 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $16.37 | 2025 | Doc Band |
| Tolmar, INC. | $13.71 | 2025 | Jatenzo |
| Halozyme INC | $13.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.